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Edited by Gianni CesareniAbstract We tested whether any intracellular signals are trans-
mitted through 4-1BB/CD137 ligand (4-1BBL), using a 4-1BB-Fc
fusion protein and 4-1BB-deﬁcient mice. Immobilized 4-1BB-Fc
fusion protein strongly inhibited osteoclastogenesis induced by
macrophage colony-stimulating factor (M-CSF) and receptor
activator of nuclear factor-jB ligand (RANKL) derived from
bone marrow macrophages (BMM). Incubation of BMM with
M-CSF increased 4-1BBL mRNA and surface expression of 4-
1BBL protein. Cross-linking 4-1BBL with immobilized 4-1BB-
Fc also dramatically reduced the number of tartrate-resistant acid
phosphatase (TRAP)-positive multinuclear cells (MNC) derived
from the BMM from 4-1BB-deﬁcient mice, suggesting that the
inhibitory eﬀect of immobilized 4-1BB on osteoclastogenesis is
due to a signal through 4-1BBL. Reverse signaling by 4-1BB-Fc
increased the level of interferon (IFN)-b in BMM and neutraliza-
tion of IFN-b reversed the inhibitory eﬀect of immobilized 4-1BB-
Fc. Inhibition of osteoclastogenesis by immobilized 4-1BB-Fc is,
therefore, at least in part, due to elevation of the level of the neg-
ative regulator, IFN-b in BMM.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Ligands of the TNF family are predominantly expressed on
activated immune cells and are distributed throughout the im-
mune system, whereas the corresponding receptors are more
broadly distributed, being found on a large variety of normal,
virally infected, and cancer cells [1,2]. Interactions between
these ligands and the corresponding receptors play an impor-
tant role in development, as well as in regulation of the im-
mune system and inﬂammatory responses. 4-1BB is strongly
expressed on activated T cells, but it is also expressed in a
variety of cells including myeloid cells [3]. It is also known to
activate dendritic cells [4], as does receptor activator of nuclear
factor-jB ligand (RANKL), an essential factor for osteoclast
diﬀerentiation [5]. 4-1BBL is also expressed on myeloid lineage
cells and on several leukemia cell lines. The pattern of*Corresponding author. Fax: +82 52 259 1694.
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could play a role in various immune responses involving
myeloid cells. An interesting characteristic of this interaction
is that bi-directional signals are generated in interacting cells
that express 4-1BBL [6–10].
Osteoclasts (OC), the cells responsible for bone resorption,
are formed from hematopoietic stem cells. OC precursors have
features in common with precursors of the monocyte and mac-
rophage cell lineage. Osteoclastogenesis requires two molecules
generated from bone marrow mesenchymal cells, macrophage
colony-stimulating factor (M-CSF) and RANKL, a member of
TNF family [11]. Cooperation between M-CSF and the
RANKL/RANK system generates an essential signal for OC
diﬀerentiation during the interaction between stromal cells
and cells of the OC lineage. Osteoclastogenesis is inhibited
by various local cytokines such as IL-4, IL-10, IL-12, and
interferon (IFN)-c. Most osteotropic factors regulating OC
diﬀerentiation also aﬀect the immune system, indicating that
the two systems are closely related. Type II IFN, IFN-c, is a
well known immune mediator that is primarily generated by
T cells and has been shown to inhibit OC diﬀerentiation and
function in vivo and in vitro [12,13]. Inhibitory eﬀects of type
I IFNs (IFN-a/b) have also been demonstrated recently [14]. A
variety of cell types produce type I IFNs in response to viral
and bacterial infections, and thus connect innate and acquired
immune responses [15].
In the present study, we investigated the role of the 4-1BB/4-
1BBL interactions in bone metabolism. Immobilized 4-1BB-Fc
fusion protein strongly inhibited OC formation from bone
marrow macrophages (BMM) stimulated by M-CSF and
RANKL. We present evidence that this inhibition is caused
by a signal through 4-1BBL on the surface of BMM, and is
due, at least in part, to an increase in the level of the negative
regulator, IFN-b, in the BMM.2. Materials and methods
2.1. Reagents
Recombinant mouse 4-1BB-Fc fusion protein expressed in human
embryonic kidney cell line, HEK-293 was obtained from KOMED
(Seoul, Korea). Recombinant mouse M-CSF, RANKL, and human
CD 30-Fc fusion protein were obtained from R & D systems, Inc.
(MN, USA). Antibodies (Ab) against anti-4-1BBL (TKS-1), CD11b
(M1/70), CD3 (145-2C11), and CD45R (RA3-6B2), and F4/80
(BM8) were from BD Pharmingen (San Diego, CA, USA), and eBio-
science (San Diego). Anti-IRF-3 Ab (FL-425x) was from Santa Cruz
Biotechnology Inc. (Santa Cruz, CA, USA). In addition, a-modiﬁed
minimum essential medium (a-MEM), and fetal bovine serum (FBS)blished by Elsevier B.V. All rights reserved.
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Rabbit polyclonal Ab against IFN-b (324001) and ELISA kit for mur-
ine IFN-b were from P.B.L. Biomedical Lab (Piscataway, NJ, USA).
2.2. Osteoclast formation
Bone marrow cells were isolated from 4 to 5-week-old C57BL/6J
mice as described [16]. C57BL/6J mice, in which the 4-1BB gene had
been deleted, were provided by the University of Ulsan Immunomod-
ulation Research Center. All mice were housed in the speciﬁc patho-
gen-free animal facility of the Immunomodulation Research Center.
Animal experimentation protocols were approved by the Institutional
Animal Care and Use Committee of the University of Ulsan Immuno-
modulation Research Center. Femora and tibiae were aseptically re-
moved and dissected free of adherent soft tissues. The bone ends
were cut, and the marrow cavity was ﬂushed out from one end of
the bone with a-MEM using a sterile 21-gauge needle. The bone mar-
row suspension was carefully agitated with a plastic Pasteur pipette to
obtain single cells. These were washed twice and resuspended in a-
MEM containing 10% FBS, and the suspension was added to plates
along with M-CSF (100 ng/ml) for 16 h, Then, non-adherent cells were
harvested and cultured for 2 more days, and large populations of
adherent monocytes/macrophage-like cells had formed on the bottom
of the culture plates. A small number of non-adherent cells and adher-
ent stromal cells were removed by washing the dishes with PBS, and by
subsequent incubation for 5 min in 0.25% trypsin/0.05% EDTA,
respectively. The remaining adherent bone marrow-derived macro-
phages (BMM) were harvested by vigorous pipetting. The isolated cells
were conﬁrmed by FACS as positive for CD11b and F4/80, and nega-
tive for CD3 and CD45R (data not shown). Absence of contaminating
stromal cells was conﬁrmed by lack of growth when M-CSF was omit-
ted (data not shown). The isolated BMM were seeded at a density of
3 · 104 cells/well in 48-well plates. To each of the wells was added addi-
tional medium containing M-CSF (20 ng/ml) and RANKL (40 ng/ml)
with or without various concentrations of coated 4-1BB-Fc. After 3
days incubation, the cells were ﬁxed in 10% formalin for 10 min, and
stained for tartrate-resistant acid phosphatase (TRAP) as described
[16]. Numbers of TRAP-positive multinucleated cells (MNC) (three
or more nuclei) were scored.
2.3. Flow cytometry
Cells (106/sample) were incubated in PFS buﬀer (phosphate based
saline, 2.5% fetal bovine serum, and 0.1% sodium azide) with anti-4-
1BBL Ab (TKS-1) (or rat IgG: isotype control) on ice for 30 min. They
were then washed three times in PFS, and incubated on ice for 30 min
with FITC-conjugated goat anti-rat IgG. The cells were washed again
as above, and examined by ﬂow cytometry with a FACS Calibur (Bec-
ton Dickinson).
2.4. RNA isolation and RT-PCR
Expression of 4-1BBL, IFN-b and GAPDH mRNA was assessed by
RT-PCR analysis. RNA was isolated from BMM cells using TRI
reagent (Sigma Chemical Co.). Total RNA was used for cDNA synthe-
sis by the reverse transcriptase supplied with the cDNA synthesis kit
(Invitrogen, SanDiego, CA). cDNAwas ampliﬁed by PCR for 35 cycles
(4-1BBL), 28 cycles (IFN-b), and 25 cycles (GAPDH)with the following
speciﬁc PCR primers: 4-1BBL, 5 0-GAGCCTCGGCCAGCGCTCAC-
3 0 (forward) and 5 0-GATAGTTCTCATTCCCATGG-3 0 (reverse);
mouse IFN-b 5 0-CCTCTCCACCACAGCCCTCTC-3 0 (forward) and
5 0-CCCACGTCAATCTTTCCTCTT-30 (reverse); mouse GAPDH,
5 0-ACCACAGTCCATGCCATCAC-30 (forward) and 5 0-TCCAC-
CACCCTGTTGCTGTA-3 0 (reverse). Each cycle consisted of 30 s of
denaturation at 94 C, 30 s of annealing at 60 C, and 30 s of extension
at 72 C. GAPDH was used as internal control. The size of the PCR
products for mouse 4-1BBL, IFN-b, and GAPDH were 623, 346, and
452 bp, respectively.
2.5. Electrophoretic mobility shift assay (EMSA)
BMM cells were stimulated with immobilized human IgG (5 lg/ml),
or 4-1BB-Fc (5 lg/ml) in the presence of M-CSF (20 ng/ml) for 2 h,
and then nuclear extracts were prepared. For IRF-3, a double-stranded
oligonucleotide probe corresponding to the PRDIII region of the IFN-
b promoter (5 0-GGAAAACTGAAAGGG-3 0) (17) was end-labeled
with [c-32P]ATP using T4 polynucleotide kinase. Five microgram ofthe nuclear extracts was incubated at 30 C for 20 min with 1 ng of
32P-labeled IRF-3 probe in 10 ll of binding buﬀer containing 1 lg of
poly(dIÆdC), 15 mM HEPES, pH 7.6, 80 mM NaCl, 1 mM EGTA,
1 mM dithiothreitol, and 10% glycerol. To demonstrate the speciﬁcity
of protein–DNA complex formation, 125-fold molar excess of unla-
beled oligonucleotide was added to the nuclear extract before adding
labeled probe. For supershift experiments, nuclear extracts were incu-
bated with speciﬁed antiserum for 16 h at 4 C prior to the addition of
the labeled oligonucleotide. DNA–nuclear protein complexes were sep-
arated from the DNA probe by electrophoresis on a native 5% poly-
acrylamide gel, and the gel was vacuum-dried and subjected to
autoradiography using an intensifying screen at 80 C.
2.6. ELISA
The isolated BMM were seeded at a density of 5 · 105 cells/well in
24-well plates. To each of the wells was added additional medium
containing M-CSF (20 ng/ml) and RANKL (40 ng/ml) with
immobilized human IgG (5 rmug/ml) or 4-1BB-Fc (5 lg/ml). The
culture medium was harvested at 8 h after incubation, and determined
for the level of IFN-b. IFN-b levels were measured by an enzyme
immunoassay kit from P.B.L. Biomedical Lab as recommended by
the manufacturer.
2.7. Statistical analysis
All values are expressed as means ± SEM. Student’s t-test was used
to evaluate diﬀerences between samples of interest and the respective
controls. For analysis of anti- IFN-b Ab-treated groups, multiple mea-
surement ANOVA was used. A P value of less than 0.05 was consid-
ered statistically signiﬁcant.3. Results
3.1. Expression of 4-1BBL is upregulated by M-CSF in BMM
Since 4-1BBL is expressed on myeloid lineage cells such as
dendritic cells and macrophages [3], we examined its expres-
sion in bone marrow-derived macrophages (BMM) using
RT-PCR and FACS analysis. Incubation of BMM with M-
CSF increased the level of 4-1BBL mRNA, and slightly lower
level was obtained by incubation with RANKL and M-CSF
(Fig. 1A). As shown in Fig. 1B, substantial level of 4-1BBL
protein was expressed on the BMM upon treatment with M-
CSF for 24 h.
3.2. Osteoclastogenesis is inhibited by 4-1BBL signaling
Since it has been suggested that 4-1BB strongly inhibits
osteoclastogenesis [10], we examined the eﬀect of 4-1BB-Fc
on the induction of OC formation from BMM by RANKL.
In the presence of M-CSF and RANKL, maximum numbers
of OC appeared after 3 d. The formation of TRAP-positive
MNCs was substantially reduced by immobilized 4-1BB-Fc.
As a negative control, immobilized human CD30-Fc caused
no signiﬁcant change in the number of TRAP-positive MNCs.
The inhibitory eﬀect of immobilized 4-1BB-Fc on OC diﬀeren-
tiation (Fig. 2A) could not be attributed to any toxic eﬀect of
4-1BB-Fc, since total cell numbers were unaﬀected (data not
shown). Nor could the eﬀects of 4-1BB-Fc be due to contam-
inating stromal cells, since no cell growth occurred without
M-CSF, indicating that no stromal cells were present (data
not shown). When 4-1BB-Fc was added in soluble form, the
reduction in TRAP-positive MNCs was much less compared
with the immobilized 4-1BB-Fc (Fig. 2B). To see whether the
inhibitory eﬀect of 4-1BB-Fc on OC formation was mediated
by stimulation of 4-1BBL, we examined the eﬀect of 4-1BB-
Fc on OC diﬀerentiation using BMM from 4-1BB deﬁcient
mice. As shown in Fig. 2C, immobilized 4-1BB-Fc again
Fig. 1. Expression of 4-1BBL on BMM cells. BMM cells were
prepared from 4 to 5-week-old C57BL/6 mice as described in Section 2
and incubated in 6-well plates (106 cells/well) in the presence of M-CSF
(20 ng/ml) with or without RANKL (40 ng/ml) for the indicated time.
Total RNA was extracted and subjected to RT-PCR analysis (A). The
cells were stained with anti-4-1BBL Ab (TKS-1) (2) [rat IgG; isotype
control (1)], further incubated with FITC-conjugated goat anti-rat
IgG, and analyzed by ﬂow cytometry (B). Similar results were obtained
in three independent experiments.
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MNCs in the absence of 4-1BB, excluding the possibility that
4-1BB-Fc acts by competition with endogenous membrane-
bound 4-1BB. In addition, anti-4-1BBL Ab suppressed the
inhibitory eﬀect of 4-1BB-Fc on osteoclastogenesis, whereas
it had no signiﬁcant eﬀect in the absence of 4-1BB-Fc
(Fig. 2D). These results indicate that the 4-1BB/4-1BBL inter-
actions strongly inhibit osteoclastogenesis and that the inhibi-
tion is a consequence of signaling through 4-1BBL.
3.3. Inhibition of osteoclastogenesis by 4-1BB-Fc is mediated by
elevated levels of IFN-b
We examined the eﬀect of type I IFN on OC diﬀerentiation,
since IFN-b is known to inhibit OC diﬀerentiation, and its
expression is upregulated by RANKL-RANK signaling [14]
although it is constitutively expressed on OC precursor cells.
IFN-b transcript level was determined by RT-PCR after stim-
ulating BMM cells with RANKL in the presence or absence of
4-1BB-Fc (Fig. 3A). IFN-b mRNA started to increase after as
little as 3 h, and reached peak level 5 h after exposure to
RANKL. Moreover the level of IFN-b mRNA was higher in
response to combined exposure to RANKL and coated 4-
1BB-Fc. In addition, coated 4-1BB-Fc alone increased IFN-b
transcript level as early as 1 h after exposure with a maximum
at 5 h (Fig. 3B). Given that many of factors that promote IFN-
b, act by stimulating IRF-3, we examined the eﬀect of immo-
bilized 4-1BB-Fc on this transcription factor. As shown in
Fig. 3C, immobilized 4-1BB-Fc induced IRF-3-DNA binding
activity in BMM (lane 2), as diagnosed by reactivity to anti-
IRF-3 Ab (lane 3). The speciﬁcity of protein–DNA bindingcomplex was examined by adding excess cold oligo-nucleotide
to immobilized 4-1BB-Fc-induced nuclear extract (lane 6).
To conﬁrm that the increase in IFN-b was responsible for
the inhibition of OC formation by 4-1BB-Fc, we added neu-
tralizing Ab against IFN-b to cultures of BMM on immobi-
lized 4-1BB-Fc or human IgG. As shown in Fig. 3D,
blockade of IFN-b stimulated OC formation when the BMM
were incubated with RANKL on plates coated with human
IgG. In addition, increasing doses of anti-IFN-b Ab progres-
sively reversed the inhibitory eﬀect of immobilized 4-1BB-Fc
on osteoclastogenesis. The fact that the latter reversal de-
pended on the dose of the neutralizing antibodies suggests that
higher levels of IFN-b were generated by the combination of
signals supplied by RANKL and immobilized 4-1BB-Fc than
by exposure to RANKL alone. To conﬁrm the increased level
of IFN-b by immobilized 4-1BB, secreted level of IFN-b was
determined by ELISA. As shown in Fig. 3E, signiﬁcantly high-
er level of IFN-b was induced by immobilized 4-1BB-Fc, com-
paring with human IgG from BMM stimulated by RANKL.
Taken together, these ﬁndings indicate that the inhibitory ef-
fect of 4-1BB-Fc on osteoclastogenesis is mediated by a signal
through 4-1BBL that leads to an increase in the level of IFN-b.4. Discussion
In this study, we have shown that immobilized 4-1BB-Fc
inhibited osteoclastogenesis induced by RANKL in BMM
cells, and that the inhibitory signals are transmitted through
4-1BBL. To explore the intracellular signaling through 4-
1BBL, we treated cells with 4-1BB-Fc after substantial levels
of 4-1BBL were expressed on BMM, and found that immobi-
lized 4-1BB-Fc reduced the yield of the TRAP-positive MNCs
characteristic of OC diﬀerentiation. Anti-4-1BBL Ab sup-
pressed the inhibitory eﬀect of 4-1BB-Fc on osteoclastogenesis,
whereas it alone did not aﬀect osteoclastogenesis signiﬁcantly.
In addition, 4-1BB-Fc dramatically inhibited osteoclastogene-
sis in BMM from 4-1BB-knockout mice, suggesting that the ef-
fect of 4-1BB-Fc was not caused by interfering 4-1BB. These
results indicate that the inhibitory signal produced by 4-1BB-
Fc is transmitted via 4-1BBL, since indirect eﬀects through
4-1BB can be ruled out in the 4-1BB-deﬁcient mice. 4-1BB acts
by cross-linking 4-1BBL. Dimerization of 4-1BBL is not suﬃ-
cient for the full inhibitory eﬀect on osteoclastogenesis, be-
cause the 4-1BB-Fc protein that we used dimerizes via its Fc
domains and yet the soluble dimeric 4-1BB protein did not in-
hibit osteoclastogenesis as eﬀectively as immobilized 4-1BB
which can induce higher-order multimerization of the ligand.
Several ligands of the TNF super-family have been shown to
transmit signals in both directions through their respective
receptors. Members of the family such as 4-1BBL, CD27L,
OX-40L, CD30L, CD40L, and GITRL have all been shown
to transduce signals [6–8,18–22]. 4-1BBL has been demon-
strated in human monocytes and performs reverse signaling
to induce IL-8, IL-6, and TNF-a production [6]. An increase
in apoptosis of activated monocytes is also observed after liga-
tion of 4-1BBL [7]. In cord blood-derived dendritic cells, re-
verse signaling by 4-1BB-Fc stimulates IL-12 production and
augments the level of 4-1BBL [8]. 4-1BBL transgenic mice that
express 4-1BBL constitutively, display splenomegaly with in-
creased numbers of macrophages, also suggesting possible re-
verse signaling [9]. The expression of 4-1BBL in OC cells
Fig. 2. Inhibition of osteoclastogenesis by immobilized 4-1BB-Fc. (A) BMM cells from 4 to 5-week-old C57BL/6 mice were prepared as described in
Section 2, and incubated in 48-well plates (3 · 104 cells/well) in the presence of M-CSF (20 ng/ml) and RANKL (40 ng/ml) together with immobilized
4-1BB-Fc (0.2, 1, 5 lg/ml), human IgG (IgG) (1 lg/ml) or human CD 30-Fc (CD30Fc) (1 lg/ml). The eﬀects of 4-1BB-Fc were statistically signiﬁcant
(*, P < 0.05; ***, P < 0.001, n = 3). (B) BMM cells were incubated in the presence of M-CSF and RANKL together with soluble 4-1BB-Fc (0, 1, 5 lg/
ml), immobilized 4-1BB-Fc (5 lg/ml; 4-1BBFc@), or human IgG (IgG@). The eﬀects of 4-1BB-Fc were statistically signiﬁcant (*, P < 0.05; ***,
P < 0.001, n = 3). (C) BMM cells from 4 to 5-week-old 4-1BB-deﬁcient mice in a C57BL/6 background were incubated in 48-well plates (3 · 104 cells/
well) in the presence of M-CSF (20 ng/ml) and RANKL (40 ng/ml) as well as immobilized 4-1BB-Fc (0.1, 0.5, 2.5 lg/ml), or human IgG (1 lg/ml).
The eﬀects of 4-1BB-Fc were statistically signiﬁcant (*, P < 0.05; ***, P < 0.001, n = 3). (D) BMM cells were incubated in the presence of M-CSF and
RANKL with immobilized 4-1BB-Fc (5 lg/ml), or human IgG (5 lg/ml). Rat IgG (1 lg/ml) or anti-4-1BBL Ab (TKS-1) (1 and 5 lg/ml) was added to
BMM (Ig; rat IgG was added to BMM in culture plates coated with human IgG, IgG/TKS-1; anti-4-1BBL Ab was added to BMM in culture plates
coated with human IgG, 4-1BBFc; rat IgG was added to BMM in culture plates coated with 4-1BB-Fc; 4-1BBFc/TKS-1; anti-4-1BBL Ab was added
to BMM in culture plates coated with 4-1BB-Fc). No statistical diﬀerence was observed between rat IgG- and TKS-1-treatment in the groups exposed
to human IgG. The diﬀerences between rat IgG- and TKS-1-treatments were statistically signiﬁcant in the groups exposed to 4-1BB-Fc (*, P < 0.05,
n = 3). After 3 days, the cells were ﬁxed and stained for TRAP, and the number of TRAP-positive MNCs per well was scored. Results are
means ± S.E.M. Similar results were obtained in three independent experiments.
1604 H.-H. Shin et al. / FEBS Letters 580 (2006) 1601–1606points to a role in bone metabolism. 4-1BB is a co-stimulatory
molecule, and its expression was induced on activated T cells.
Soluble 4-1BB from activated lymphocytes has been shown to
involve in chronic inﬂammation such as rheumatic arthritis
[23], suggesting a role of 4-1BB/4-1BBL interaction in chronic
inﬂammation. Once produced, the secreted proteins could act
in a paracrine fashion to stimulate the cells that express 4-
1BBL in the adjacent microenvironment. Or inﬁltrated T cells
that express high level of 4-1BB on the surface could act with
4-1BBL-bearing OCs. It is possible that the 4-1BB/4-1BBL
interactions inhibit OC diﬀerentiation by diverting cells to
the other lineage as a result of the increased level of IFN-b. Re-
cently, Saito et al. [10] demonstrated that immobilized recom-
binant 4-1BB protein inhibits OC formation from bone
marrow cells. They suggested that reverse signaling was
responsible since both recombinant 4-1BB extracellular do-
main and a high concentration (8, 10 lg/ml) of anti-4-1BBL
Ab (TKS-1) inhibited OC formation, and casein kinase I inhib-
itor suppressed the inhibition by recombinant 4-1BB. Our data
also point to reverse signaling, but we used low concentrations
(1, 5 lg/ml) of anti-4-1BBL Ab (TKS-1) to neutralize 4-1BBL.Bi-directional transmission of signals through receptor and
ligand may allow the ﬁne-tuning of immune responses by
delivering a direct and immediate feedback signal to the
ligand-bearing cell.
Although reverse signaling has been reported with subgroup
of TNFR, any binding protein that associates with the ligand
has not been identiﬁed yet. Transcriptional expression of IFN-
b is regulated by an enhancer region located upstream of the
transcription start site, although it is controversial. The bind-
ing of NF-jB and ATF-2/c-Jun are important along with
IRF regulatory factors such as IRF-3 and IRF-7 for the for-
mation of enhancesome of IFN-b [24], whereas Peters et al.
has demonstrated that IRF-3 activation is suﬃcient for IFN-
b induction with blockade of NF-jB and AP-1 activities [25].
Since IRF-7 is induced by activated IRF-3, and IRF-3 and
IRF-7 preferably bound to the PRDIII and PRDI probe,
respectively [17], we have observed activation of IRF-3 by
immobilized 4-1BB-Fc, using a PRDIII probe in EMSA.
Our data suggests that immobilized 4-1BB-Fc activates IRF-
3 and induces IRF-3-DNA binding by EMSA. The speciﬁcity
of IRF-3-DNA binding was shown by disappearance when
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Addition of anti-IRF-3 Ab may disrupt the formation of the
complex rather than increasing its molecular weight. Viral
infections results in phosphorylation of constitutively ex-
pressed IRF-3, whereas IFN-b induction by RANKL is not
dependent on IRF-3 or IRF-7 but on c-Fos [26]. Signaling
pathways of IFN-b production by 4-1BB/4-1BBL interaction
appears to be more closely related to those by viral infection
than by RANKL. Saito et al. also showed that immobilized
4-1BB did not aﬀect the expression of c-Fos of BMM cultured
with RANKL [10]. However, it blocked RANKL-induced
phosphoinositide 3-kinase (PI3K) activation. The interaction
of PI3K and IRF-3 is controversial. Activation of PI3K isneeded to fully activate IRF-3 [27], whereas inhibition of
PI3K was found to enhance IFN-b expression by increased
DNA-binding activity of NF-jB, but not IRF-3 [28]. Although
IFN-b is produced in the absence of viral infection, its produc-
tion mechanism under this condition is not clearly elucidated.
In addition to enhancesome, the IFN-b promoter is also regu-
lated under a negative control by repressors [29]. It is possible
that 4-1BB/4-1BBL interaction not only activates IRF-3, but
also inhibits repression by a mechanism related to PI3K path-
way to induce IFN-b. Further studies are necessary to eluci-
date the signaling pathway through 4-1BBL to the promoter
region of IFN-b.
A strict balance between bone resorption and bone forma-
tion is important for maintaining bone homeostasis. However,
tipping the balance in favor of OC formation results in bone
destruction, which is frequently observed in pathological con-
ditions such as autoimmune arthritis, osteoporosis, and bone
tumors. Excessive stimulation of RANKL, which is essential
for OC diﬀerentiation, or the absence of negative regulators,
could be responsible for these pathological conditions. IFN-b
was originally found to be induced upon viral infection and
to elicit strong antiviral activity in target cells of the innate im-
mune system. Recently interferon receptor chain-1-deﬁcient
mice and IFN-b-deﬁcient mice were found to have a signiﬁcant
reduction in trabecular bone mass with an increase in the num-
ber of OCs [26], indicating that IFN-b signaling is critical for
maintaining normal bone mass by virtue of its inhibitory eﬀectFig. 3. Eﬀects of immobilized 4-1BB-Fc on expression of IFN-b, and
eﬀect of neutralization of IFN-b on OC formation in response to
immobilized 4-1BB-Fc. (A) BMM cells from 4 to 5-week-old C57BL/6
mice were prepared as described in Section 2 and incubated in 6-well
plates (106 cells/well) in the presence of M-CSF (20 ng/ml) and
RANKL (R) (40 ng/ml) with or without immobilized 4-1BB-Fc
(5 lg/ml) for 0, 1, 3, 5, and 8 h. (B) BMM cells were incubated in
the presence of M-CSF (20 ng/ml) with immobilized 4-1BB-Fc (5 lg/
ml) for 0, 1, 3, 5, and 8 h. Total RNA was extracted and subjected to
RT-PCR analysis. (C) BMM cells were incubated in the presence of M-
CSF (20 ng/ml) in 6-well plates (107 cells/well) coated with 5 lg/ml of
human IgG (lane 1) or 4-1BB-Fc (lanes 2–6) for 2 h. Nuclear extracts
were prepared and analyzed by EMSA with an IRF-3-binding oligo-
nucleotide probe as described in Section 2. Super-shift assays on the
4-1BB-Fc-induced IRF-3 binding complex were performed with anti-
IRF-3 Ab (lane 3), or rabbit IgG (lane 4). To demonstrate the
speciﬁcity of protein–DNA complex formation, 125-fold molar excess
of unlabeled oligo-nucleotide was added to the nuclear extract before
adding labeled probe (lane 6). The IRF-3-oligo-nucleotide complex
induced by immobilized 4-1BB-Fc is indicated by the arrow. (D) BMM
cells were incubated in the presence of M-CSF (20 ng/ml) and RANKL
(40 ng/ml) in 48-well plates (3 · 104 cells/well) coated with 4-1BB-Fc
(Fc) (5 lg/ml) or human IgG (IgG). Polyclonal anti- IFN-b Ab
(5, 20, 100 U/ml) or rabbit IgG was added. After 3 days, cells were
ﬁxed and stained for TRAP, and the number of TRAP-positive MNCs
per well was scored. Results are means ± S.E.M. There was no
statistically signiﬁcant eﬀect of the diﬀerent concentrations of poly-
clonal anti-IFN-b Ab in the groups incubated with immobilized
human IgG. The diﬀerent concentrations of polyclonal anti- IFN-b Ab
did show a statistically signiﬁcant diﬀerence in the groups incubated on
immobilized 4-1BB-Fc (*, P < 0.05 by ANOVA). The numbers above
the histograms are ratios of the number of MNCs formed in the group
exposed to 4-1BB-Fc to the number formed in the corresponding
group exposed to human IgG. (E) BMM cells were incubated in the
presence of M-CSF (20 ng/ml) and RANKL (40 ng/ml) in 24-well
plates (5 · 105 cells/well) coated with 4-1BB-Fc (5 lg/ml) or human
IgG (IgG) for 8 h. The supernatant was determined for the level of
IFN-b by ELISA. The eﬀects of 4-1BB-Fc were statistically signiﬁcant
(***, P < 0.001, n = 3). Similar results were obtained in three indepen-
dent experiments.
b
1606 H.-H. Shin et al. / FEBS Letters 580 (2006) 1601–1606on OC formation. In our study, immobilized 4-1BB-Fc in-
creased transcript and protein levels of IFN-b in BMM. There
are low levels of 4-1BBL on the surface of bone marrow pro-
genitor cells and exposure of BMM to M-CSF increased these
levels. The increased expression of 4-1BBL on the surface of
the BMM could facilitate the response to 4-1BB-Fc leading
to inhibition of osteoclastogenesis. Signaling through
RANKL/RANK stimulates induction of IFN-b [14], and
RANKL together with immobilized 4-1BB-Fc generated high-
er levels of IFN-b mRNA and protein than RANKL on its
own. In addition, exposure to immobilized 4-1BB-Fc by itself
also induced expression of IFN-b. It should be noted that
blockade of IFN-b only partially suppressed the inhibitory ef-
fect of 4-1BB-Fc, indicating that unknown factors may be in-
volved in the inhibition of osteoclastogenesis by 4-1BB-Fc.
In summary, we have shown that immobilized 4-1BB-Fc
inhibits osteoclastogenesis in BMM via a signal through 4-
1BBL. The signal through 4-1BBL results in the production
of a high level of IFN-b , a negative regulator of osteoclasto-
genesis, upon stimulation with RANKL, and leads to inhibi-
tion of osteoclastogenesis.
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